Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul M Karpecki

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Ophthalmology and Therapy|October 28, 2021
Review of Loteprednol Etabonate 0.5%/Tobramycin 0.3% in the Treatment of BlepharokeratoconjunctivitisFrancis S Mah, Paul M Karpecki
Clinical Ophthalmology (Auckland, N.Z.)|December 10, 2020
A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation DevelopmentsLaura M Periman, Francis S Mah, Paul M Karpecki
The Ocular Surface|October 7, 2014
Treatment of blepharitis: recent clinical trialsStephen C Pflugfelder, Paul M Karpecki, Victor L Perez
The American Journal of Managed Care|October 16, 2023
Addressing excessive evaporation: an unmet need in dry eye diseasePaul M Karpecki, Kelly K Nichols, John D Sheppard
Current Eye Research|November 26, 2020
A Comprehensive Review of the Clinical Trials Conducted for Dry Eye Disease and the Impact of the Vehicle Comparators in These TrialsKelly K Nichols, David G Evans, Paul M Karpecki
American Journal of Ophthalmology|September 1, 2024
Silk-Derived Protein-4 Versus Vehicle Control in Treating Patients With Moderate to Severe Dry Eye Disease: A Randomized Clinical TrialBrian D Lawrence, Paul M Karpecki, David W Infanger, et al.
The American Journal of Managed Care|April 15, 2021
Evolving knowledge of the unmet needs in dry eye diseaseJeffrey D Dunn, Paul M Karpecki, Mary Elizabeth Meske, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 25, 2015
An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eyeGeorge Ousler, Douglas K Devries, Paul M Karpecki, et al.
Clinical Ophthalmology (Auckland, N.Z.)|May 14, 2010
Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitisTimothy L Comstock, Paul M Karpecki, Timothy W Morris, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 11, 2019
Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry EyeDarrell E White, Yang Zhao, Abayomi Ogundele, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Ophthalmology and Therapy|October 28, 2021
Review of Loteprednol Etabonate 0.5%/Tobramycin 0.3% in the Treatment of BlepharokeratoconjunctivitisFrancis S Mah, Paul M Karpecki
Clinical Ophthalmology (Auckland, N.Z.)|December 10, 2020
A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation DevelopmentsLaura M Periman, Francis S Mah, Paul M Karpecki
The Ocular Surface|October 7, 2014
Treatment of blepharitis: recent clinical trialsStephen C Pflugfelder, Paul M Karpecki, Victor L Perez
The American Journal of Managed Care|October 16, 2023
Addressing excessive evaporation: an unmet need in dry eye diseasePaul M Karpecki, Kelly K Nichols, John D Sheppard
Current Eye Research|November 26, 2020
A Comprehensive Review of the Clinical Trials Conducted for Dry Eye Disease and the Impact of the Vehicle Comparators in These TrialsKelly K Nichols, David G Evans, Paul M Karpecki
American Journal of Ophthalmology|September 1, 2024
Silk-Derived Protein-4 Versus Vehicle Control in Treating Patients With Moderate to Severe Dry Eye Disease: A Randomized Clinical TrialBrian D Lawrence, Paul M Karpecki, David W Infanger, et al.
The American Journal of Managed Care|April 15, 2021
Evolving knowledge of the unmet needs in dry eye diseaseJeffrey D Dunn, Paul M Karpecki, Mary Elizabeth Meske, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 25, 2015
An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eyeGeorge Ousler, Douglas K Devries, Paul M Karpecki, et al.
Clinical Ophthalmology (Auckland, N.Z.)|May 14, 2010
Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitisTimothy L Comstock, Paul M Karpecki, Timothy W Morris, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 11, 2019
Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry EyeDarrell E White, Yang Zhao, Abayomi Ogundele, et al.
Pageof 3